Search

Your search keyword '"Slabbynck, Hans"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Slabbynck, Hans" Remove constraint Author: "Slabbynck, Hans"
165 results on '"Slabbynck, Hans"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

3. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

4. Clinical course of suspected familial and sporadic idiopathic pulmonary fibrosis: Data from the PROOF‐Next registry.

7. Correlation of BAL Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data From the Belgium-Luxembourg Idiopathic Pulmonary Fibrosis Registry.

10. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

11. Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

12. Correlation of Broncho-Alveolar Lavage Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data from the Belgium-Luxembourg IPF registry

13. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.

14. Correlation of Broncho-Alveolar Lavage Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data from the Belgium-Luxembourg IPF registry.

15. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

16. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

17. Early treatment with inhaled GM-CSF improves oxygenation and anti-viral immunity in COVID-19 induced lung injury – a randomized clinical trial

22. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

25. Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

26. MOESM1 of Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo â a post-hoc analysis of the BACE randomized controlled trial

27. MOESM1 of Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

28. Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicentre, Randomized, Double-blind, Placebo-controlled Trial

29. Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - A post-hoc analysis of the BACE randomized controlled trial

30. Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicentre, Randomized, Double-blind, Placebo-controlled Trial.

31. Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: The PROOF registry

34. Diagnostic ability of a dynamic multidisciplinary discussion in Interstitial Lung Diseases: a retrospective observational study of 938 cases

39. Overuse of inhaled corticosteroids in COPD: Five questions for withdrawal in daily practice

40. Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.

41. Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: The PROOF registry

42. Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice

43. Thoracoscopic findings in spontaneous pneumothorax in AIDS

44. Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

46. Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results

49. Dyspnea in homosexual male patients: throwback to an occasionally forgotten but severe clinical presentation of HIV/AIDS

50. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: An investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

Catalog

Books, media, physical & digital resources